Blue Sky Capital Consultants Group Inc. Buys New Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Blue Sky Capital Consultants Group Inc. acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 655 shares of the medical equipment provider's stock, valued at approximately $342,000.

Several other large investors have also recently bought and sold shares of the company. Warm Springs Advisors Inc. acquired a new position in Intuitive Surgical during the 4th quarter worth $991,000. Cache Advisors LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at $240,000. GF Fund Management CO. LTD. bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at $38,798,000. University of Texas Texas AM Investment Management Co. raised its position in shares of Intuitive Surgical by 405.5% during the 4th quarter. University of Texas Texas AM Investment Management Co. now owns 2,669 shares of the medical equipment provider's stock valued at $1,393,000 after acquiring an additional 2,141 shares during the last quarter. Finally, Vega Investment Solutions bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at $4,660,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Transactions at Intuitive Surgical

In other news, VP Fredrik Widman sold 810 shares of the stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $573.78, for a total transaction of $464,761.80. Following the completion of the transaction, the vice president now directly owns 473 shares in the company, valued at $271,397.94. This represents a 63.13% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of the stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the transaction, the director now owns 6,371 shares of the company's stock, valued at approximately $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 32,700 shares of company stock worth $16,865,621 in the last three months. Insiders own 0.70% of the company's stock.

Intuitive Surgical Price Performance

ISRG stock traded up $10.65 during trading hours on Tuesday, reaching $550.19. 1,243,739 shares of the stock were exchanged, compared to its average volume of 1,645,228. The firm's 50-day moving average is $512.50 and its 200-day moving average is $538.12. The company has a market cap of $197.20 billion, a price-to-earnings ratio of 85.83, a PEG ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 12 month low of $396.15 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. During the same quarter in the prior year, the company earned $1.50 EPS. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages have commented on ISRG. Bernstein Bank upped their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a research report on Monday, January 27th. Barclays dropped their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research report on Thursday, April 24th. Erste Group Bank cut shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research report on Monday, March 17th. Piper Sandler lowered their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research report on Wednesday, April 23rd. Finally, Evercore ISI lowered their price objective on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research report on Wednesday, April 23rd. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $596.05.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.